About Godavari Drugs Ltd
Godavari Drugs Limited, established in 1987, specializes in manufacturing Active Pharmaceutical Ingredients (APIs) and drug intermediates at its facility in Nanded, Maharashtra, India. The company's flagship product, Sulphamethoxazole (SMX), is a widely demanded antibacterial drug, particularly for export markets. Godavari Drugs has expanded its SMX production capacity from 540 to 720 tons per annum (tpa) and integrated backward into manufacturing intermediates like sulphamethoxide (450 tpa) and diethyl oxalate (750 tpa). Additionally, the company has diversified into producing Trimethoprim (TMP) with a capacity of 144 tpa, enhancing its product offerings for infection treatments.
Godavari Drugs has also introduced 'Pyrazyamide' to the market and plans to boost its production to 180 tpa, alongside developing Cislactum, an intermediate for the anti-anginal drug Diltiazem. The company leverages its chemistry and engineering expertise to efficiently scale and manufacture products from laboratory to commercial levels, adhering to cGMP standards. This combination of capabilities positions it well for continued growth and market expansion. Founded 1987
Headquarters Secunderabad
